Cost-Effectiveness Analysis of Rifaximin-Α Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.966
https://www.valueinhealthjournal.com/article/S1098-3015(16)32332-4/fulltext
Title :
Cost-Effectiveness Analysis of Rifaximin-Α Administration for the Reduction of the Overt Hepatic Encephalopathy Episodes in Recurrence in France
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32332-4&doi=10.1016/j.jval.2016.09.966
First page :
A513
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
906